Herriot Tabuteau

Chief Executive Officer, Director, 10% owner, Axsome Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$97.8M

Companies

Latest trade

Aug 6, 2026

Companies

Axsome Therapeutics, Inc.Chief Executive Officer, Director, 10% owner −$103M

Trades

AXSM Sold 4,660 shares at $213.95 · planned $1.0M Aug 6

AXSM Sold 45,004 shares at $212.01 · planned $9.5M Aug 5

AXSM Sold 49,666 shares at $240.25 · planned $11.9M Jul 1

AXSM Sold 49,670 shares at $241.01 · planned $12.0M Jun 9

AXSM Sold 32,410 shares at $185.60 · planned $6.0M Feb 2

AXSM Sold 31,261 shares at $170.38 · planned $5.3M Jan 7

AXSM Sold 29,450 shares at $172.33 · planned $5.1M Jan 6

AXSM Sold 78,703 shares at $171.28 · planned $13.5M Jan 5

AXSM Sold 10,558 shares at $148.18 · planned $1.6M Dec 4

AXSM Sold 20,163 shares at $146.94 · planned $3.0M Dec 3

AXSM Sold 49,252 shares at $144.59 · planned $7.1M Dec 2

AXSM Sold 21,775 shares at $134.49 · planned $2.9M Nov 5

AXSM Sold 50,459 shares at $133.79 · planned $6.8M Nov 4

AXSM Sold 91,705 shares at $132.34 · planned $12.1M Nov 3

AXSM Sold 12,774 shares at $118.84 · planned $1.5M Oct 8

AXSM Sold 13,390 shares at $118.77 · planned $1.6M Oct 7

AXSM Sold 19,220 shares at $120.17 · planned $2.3M Oct 6

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.